All In MedTech

FDA Clearance Tracker · P010015-S385

Percepta Quad CRT-P MRI SureScan, Serena Quad CRT-P MRI SureScan, Solara Quad CRT-P MRI SureScan and Implantable Pulse G

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 10, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 10, 2019

Approved

Time to decision

166 days

Received Oct 26, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010015-S385
Device name
Percepta Quad CRT-P MRI SureScan, Serena Quad CRT-P MRI SureScan, Solara Quad CRT-P MRI SureScan and Implantable Pulse G
Applicant location
Mounds View, MN
Received
Oct 26, 2018
Decided
Apr 10, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P010015

Device type

Device class
Class III

Every decision under product code LWP

FDA's approval statement

As written in FDA's record.

Approval for the Attain Stability™ Quad MRI SureScan™ Model 4798 left ventricular (LV) lead.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.